title: Rescue therapy with anti-CD20 treatment in neuroimmunologic breakthrough disease.
authors: Andrew
authors: A
authors: Chan
authors: De-Hyung
authors: DH
authors: Lee
authors: Ralf
authors: R
authors: Linker
authors: Alexander
authors: A
authors: Mohr
authors: Klaus V
authors: KV
authors: Toyka
authors: Ralf
authors: R
authors: Gold
mesh_terms: D000328:Adult; D000906:Antibodies / Q000627:therapeutic use*; D018951:Antigens, CD20 / Q000276:immunology*; D005260:Female; D006801:Humans; D008279:Magnetic Resonance Imaging; D009157:Myasthenia Gravis / Q000188:drug therapy* / Q000276:immunology; D011950:Receptors, Cholinergic / Q000276:immunology
chemical_list: D000906:Antibodies; D018951:Antigens, CD20; D011950:Receptors, Cholinergic
references: Arch Neurol. 2005 Oct;62(10):1620-3
references: 16216948
references: Ann Neurol. 2006 Jun;59(6):880-92
references: 16718690
references: Neurology. 2005 Apr 12;64(7):1270-2
references: 15824362
references: Neurology. 1983 Oct;33(10):1316-21
references: 6684226
references: Transfus Sci. 1998 Mar;19 Suppl:43-6
references: 10178693
references: Arch Neurol. 2005 Feb;62(2):258-64
references: 15710854
references: Trends Mol Med. 2001 Mar;7(3):115-21
references: 11286782
references: Lancet. 2005 Aug 13-19;366(9485):579-82
references: 16099294
references: Annu Rev Immunol. 2006;24:467-96
references: 16551256
references: Muscle Nerve. 1983 Jun;6(5):386-7
references: 6888417